Search Results - "Goutte, M."

Refine Results
  1. 1

    Diffusion‐weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease by Buisson, A., Hordonneau, C., Goutte, M., Boyer, L., Pereira, B., Bommelaer, G.

    “…Summary Background Magnetic resonance entero‐colonography enables accurate assessment of ileocolonic Crohn's disease, but the need for bowel cleansing and…”
    Get full text
    Journal Article
  2. 2

    Faecal chitinase 3‐like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases by Buisson, A., Vazeille, E., Minet‐Quinard, R., Goutte, M., Bouvier, D., Goutorbe, F., Pereira, B., Barnich, N., Bommelaer, G.

    Published in Alimentary pharmacology & therapeutics (01-05-2016)
    “…Summary Background Faecal biomarkers are emerging tools in the assessment of mucosal healing in inflammatory bowel diseases (IBDs). Aim To evaluate the…”
    Get full text
    Journal Article
  3. 3

    Migraine prevalence in inflammatory bowel disease patients: A tertiary‐care centre cross‐sectional study by Moisset, X., Bommelaer, G., Boube, M., Ouchchane, L., Goutte, M., Dapoigny, M., Dallel, R., Guttmann, A., Clavelou, P., Buisson, A.

    Published in European journal of pain (01-10-2017)
    “…Background Inflammatory bowel diseases (IBD) are systemic, chronic inflammatory conditions that predominately affect the gastrointestinal tract and can induce…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Colonic overexpression of the T‐type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients by Scanzi, J., Accarie, A., Muller, E., Pereira, B., Aissouni, Y., Goutte, M., Joubert‐Zakeyh, J., Picard, E., Boudieu, L., Mallet, C., Gelot, A., Ardid, D., Carvalho, F. A., Dapoigny, M.

    Published in Neurogastroenterology and motility (01-11-2016)
    “…Background Among the different mechanisms involved in irritable bowel syndrome (IBS) physiopathology, visceral hypersensitivity seems to play a key role. It…”
    Get full text
    Journal Article
  6. 6

    Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn’s Disease by Goutorbe, F., Goutte, M., Minet-Quinard, R., Boucher, A-L., Pereira, B., Bommelaer, G., Buisson, A.

    Published in Journal of Crohn's and colitis (01-12-2015)
    “…Background and Aims: Fecal calprotectin [fcal] is a biomarker of Crohn’s disease [CD] endoscopic activity. Identifying the endoscopic situations in which fcal…”
    Get full text
    Journal Article
  7. 7

    Biliary stenting is not a prerequisite to endoscopic placement of duodenal covered self-expandable metal stents by Poincloux, L., Goutorbe, F., Rouquette, O., Mulliez, A., Goutte, M., Bommelaer, G., Abergel, A.

    Published in Surgical endoscopy (01-02-2016)
    “…Background Duodenal covered self-expandable metal stent (cSEMS) can be used in malignant or benign gastroduodenal obstruction. The need for biliary stenting in…”
    Get full text
    Journal Article
  8. 8

    Relationship between nutritional status and quality of life in patients with cancer by Nourissat, A, Vasson, M.P, Merrouche, Y, Bouteloup, C, Goutte, M, Mille, D, Jacquin, J.P, Collard, O, Michaud, P, Chauvin, F

    Published in European journal of cancer (1990) (01-06-2008)
    “…Abstract Patients with cancer frequently suffer a deteriorated quality of life and this is an important factor in the therapeutic decision. The correlation…”
    Get full text
    Journal Article
  9. 9

    An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis by Yuksel, E. S., Slaughter, J. C., Mukhtar, N., Ochieng, M., Sun, G., Goutte, M., Muddana, S., Gaelyn Garrett, C., Vaezi, M. F.

    Published in Neurogastroenterology and motility (01-05-2013)
    “…Background Diagnostics for gastro‐esophageal reflux disease (GERD) are suboptimal because of limited sensitivity. We performed in vitro and in vivo studies to…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Colonic overexpression of the T-type calcium channel Ca v 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients by Scanzi, J, Accarie, A, Muller, E, Pereira, B, Aissouni, Y, Goutte, M, Joubert-Zakeyh, J, Picard, E, Boudieu, L, Mallet, C, Gelot, A, Ardid, D, Carvalho, F A, Dapoigny, M

    Published in Neurogastroenterology and motility (01-11-2016)
    “…Among the different mechanisms involved in irritable bowel syndrome (IBS) physiopathology, visceral hypersensitivity seems to play a key role. It involves…”
    Get full text
    Journal Article
  12. 12

    Colonic overexpression of the T-type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients by Scanzi, J, Accarie, A, Muller, E, Pereira, B, Aissouni, Y, Goutte, M, Joubert-Zakeyh, J, Picard, E, Boudieu, L, Mallet, C, Gelot, A, Ardid, D, Carvalho, F A, Dapoigny, M

    Published in Neurogastroenterology and motility (01-11-2016)
    “…BACKGROUNDAmong the different mechanisms involved in irritable bowel syndrome (IBS) physiopathology, visceral hypersensitivity seems to play a key role. It…”
    Get full text
    Journal Article
  13. 13

    Dilated intercellular space in chronic laryngitis and gastro‐oesophageal reflux disease: at baseline and post‐lansoprazole therapy by Vaezi, M. F., Slaughter, J. C., Smith, B. S., Washington, M. K., Jerome, W. G., Garrett, C. G., Hagaman, D., Goutte, M.

    Published in Alimentary pharmacology & therapeutics (01-10-2010)
    “…Aliment Pharmacol Ther 2010; 32: 916–924 Summary Background  Dilation of intercellular spaces is reported to be an early morphological marker in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    P504 The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease by Sollelis, E, Minet Quinard, R, Bouguen, G, Goutte, M, Goutorbe, F, Bouvier, D, Pereira, B, Bommelaer, G, Buisson, A

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background Mucosal healing is recognised hitherto as the best therapeutic endpoint in patients with Crohn’s disease (CD) but its use in daily practice…”
    Get full text
    Journal Article
  19. 19

    P304 Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn’s disease by Allimant, C, Messadeg, L, Minet Quinard, R, Goutte, M, Bouvier, D, Goutorbe, F, Pereira, B, Bommelaer, G, Hordonneau, C, Buisson, A

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background Mucosal healing (MH) is to date the most validated target in Crohn’s disease (CD). However, its use is limited by the low acceptability of…”
    Get full text
    Journal Article
  20. 20

    P009 Autophagy-related host factors are implicated in the incapability of macrophages from Crohn’s disease patients to mediate adherent-invasive E. coli clearance by Douadi, C, Buisson, A, Ouchchane, L, Goutte, M, Hugot, J -P, Dubois, A, Minet-Quinard, R, Bouvier, D, Bommelaer, G, Vazeille, E, Barnich, N

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background Several experimental data have highlighted the potential role of intestinal macrophages in the pathogenesis of Crohn’s disease (CD). These…”
    Get full text
    Journal Article